Biocept (BIOC) Reports Q3 Loss of $0.24
Get Alerts BIOC Hot Sheet
Join SI Premium – FREE
Biocept (NASDAQ: BIOC) reported Q3 EPS of ($0.24), versus ($0.87) reported last year. Revenue for the quarter came in at $165 million, versus $10 thousand reported last year.
For earnings history and earnings-related data on Biocept (BIOC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Midday movers: RH, Estee Lauder rise; Tesla falls
- Can-Fite BioPharma (CANF) Reports FY23 Results, Issues Clinical Update
- NaaS Technology Inc. (NAAS) Reports Q1 Loss of $0.29
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!